| Steven Meranze, MD | |
|
3601 Tvc, Nashville, TN 37232-0001 | |
| (615) 322-3000 | |
| Not Available |
| Full Name | Steven Meranze |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 45 Years |
| Location | 3601 Tvc, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043302458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD0000023516 (Tennessee) | Secondary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | MD0000023516 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
Edison Pharmaceuticals today announced the initiation of a phase 2B study entitled, "Safety and Efficacy Study of EPI-743 on Visual Function in Patients with Friedreich's Ataxia."
Recql5 is a member of the mammalian RecQ helicase family. Genetic mutations that result in loss of RecQ helicase activity give rise to disorders that are associated with cancer predisposition and premature aging, such as Bloom, Werner, and Rothmund-Thomson syndromes. This class of enzymes is best known for their role in maintaining the integrity of the genome to prevent oncogenic mutations.
The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge.
Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval from the US Food and Drug Administration for its Investigational Device Exemption (IDE) application to initiate clinical study of the company's Pyrocarbon Implant Replacement (PIR) System.
› Verified 6 days ago
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
Edison Pharmaceuticals today announced the initiation of a phase 2B study entitled, "Safety and Efficacy Study of EPI-743 on Visual Function in Patients with Friedreich's Ataxia."
Recql5 is a member of the mammalian RecQ helicase family. Genetic mutations that result in loss of RecQ helicase activity give rise to disorders that are associated with cancer predisposition and premature aging, such as Bloom, Werner, and Rothmund-Thomson syndromes. This class of enzymes is best known for their role in maintaining the integrity of the genome to prevent oncogenic mutations.
The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge.
Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval from the US Food and Drug Administration for its Investigational Device Exemption (IDE) application to initiate clinical study of the company's Pyrocarbon Implant Replacement (PIR) System.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Meranze, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: (615) 936-2000 | Steven Meranze, MD 3601 Tvc, Nashville, TN 37232-0001 Ph: (615) 322-3000 |
News Archive
Edison Pharmaceuticals today announced the initiation of a phase 2B study entitled, "Safety and Efficacy Study of EPI-743 on Visual Function in Patients with Friedreich's Ataxia."
Recql5 is a member of the mammalian RecQ helicase family. Genetic mutations that result in loss of RecQ helicase activity give rise to disorders that are associated with cancer predisposition and premature aging, such as Bloom, Werner, and Rothmund-Thomson syndromes. This class of enzymes is best known for their role in maintaining the integrity of the genome to prevent oncogenic mutations.
The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge.
Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval from the US Food and Drug Administration for its Investigational Device Exemption (IDE) application to initiate clinical study of the company's Pyrocarbon Implant Replacement (PIR) System.
› Verified 6 days ago
Dr. Paul Allen Rosenblatt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Road, Rudy Cancer Center, Nashville, TN 37205 Phone: 615-222-6755 Fax: 615-222-3567 | |
Arthur Fleischer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Dr. Cari L Motuzas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1161 21st Ave S, Ccc-1121 Med Ctr N, Department Of Radiology, Nashville, TN 37232 Phone: 615-322-3780 | |
John O Nunes, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 25th Ave N Ste 1204, Nashville, TN 37203 Phone: 615-312-0600 | |
Dr. Christopher C Ng, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 25th Ave N Ste 1204, Nashville, TN 37203 Phone: 615-312-0600 | |
Jennifer Leslie Robinson Williams, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Dr. Robert J Stallworth, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 210 25th Ave N Ste 602, Nashville, TN 37203 Phone: 615-312-0600 Fax: 615-320-3259 |